Now, the new FDA approval means that patients will be able use the ketamine-derived nasal spray, which is marketed under the ...

It's called Spravato, and it's made by Johnson and Johnson. And Spravato is unique because it's a derivative of ketamine, best known as an illicit club drug. What impact has Spravato had on your life?

Enter psychedelics like ketamine, psilocybin, and MDMA, which are being explored as tools to access and process these buried experiences. They offer a non-linear, ego-dissolving space where ...

In 2019, the FDA approved Spravato, "a nasal spray derived from ketamine," for treating severe depression. "But that approval came with strict guardrails to ensure patient safety," added the Post ...

Stella Mental Health in Westmont specializes in medication management, Spravato (esketamine) nasal spray, transcranial magnetic stimulation (TMS), ketamine infusion therapy, stellate ganglion ...

Ketamine therapy is used in the treatment of ... LifeStance Health in Oklahoma also provides nasal spray Spravato (esketamine), another therapeutic option for treatment-resistant depression.

They also note that the oral tablets would be less prone to abuse and diversion than other ketamine formulations. They could also be cheaper, given that Spravato's US list price in the US is $590 ...

This is because the Food and Drug Administration (FDA) only approves the drug ketamine for use in general anesthetics. However, Medicare may cover the drug Spravato, which contains esketamine.

In 2019, the FDA approved a nasal spray containing a form of ketamine called esketamine (sold under the brand name Spravato) for patients with depression who hadn’t responded to other treatments.

For those who need additional support, Relief Mental Health offers psychiatric medication management, transcranial magnetic stimulation (TMS), SPRAVATO® (esketamine), and ketamine infusions ...

When Therapy Alone Isn't Enough, Options Like TMS and SPRAVATO® Provide Additional Relief OAK BROOK, Ill., April 8, 2025 ...